Infection and Immunity in Animals

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Immunological Responses and Immune Defense Mechanisms".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 1104

Special Issue Editor


E-Mail Website
Guest Editor
College Veterinary Medicine, Yangzhou University, Yangzhou 225009, China
Interests: infection and immunity; innate immune signaling; comparative immunology; anti-viral immunity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

(1) We are pleased to invite you to contribute a paper related to our topic, entitled "Infection and Immunity in Animals".

Infectious diseases are considered the largest threat to sustainable development, especially for animals reared in groups or flocks, as infection in one animal can infect the whole herd. Therefore, the prevention and control of animal infection diseases not only meet the urgent needs of animal welfare and the sustainable development of the animal breeding industry, but also benefit human health and societal stability. The method by which to efficiently combat infectious agents, including bacteria, viruses, and parasites, is now more important than ever. Understanding the mechanisms of pathogenesis caused by bacteria, viruses, and parasites plays a key role in preventing infectious diseases in animals.

(2) This Special Issue aims to present the latest findings regarding host–pathogen interaction and will cover all topics concerning the pathogenesis, virulence, and control strategies of animal epidemic disease.

(3) In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: infectious diseases of animals and immunity of animals.

We look forward to receiving your contributions.

Dr. Wanglong Zheng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pathogenesis
  • bacterium
  • virus
  • parasite
  • innate immunity
  • adaptive immunity
  • immune evasion
  • animal epidemic disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 3357 KiB  
Review
How Does African Swine Fever Virus Evade the cGAS-STING Pathway?
by Can Lin, Chenyang Zhang, Nanhua Chen, François Meurens, Jianzhong Zhu and Wanglong Zheng
Pathogens 2024, 13(11), 957; https://doi.org/10.3390/pathogens13110957 - 2 Nov 2024
Viewed by 920
Abstract
African swine fever (ASF), a highly infectious and devastating disease affecting both domestic pigs and wild boars, is caused by the African swine fever virus (ASFV). ASF has resulted in rapid global spread of the disease, leading to significant economic losses within the [...] Read more.
African swine fever (ASF), a highly infectious and devastating disease affecting both domestic pigs and wild boars, is caused by the African swine fever virus (ASFV). ASF has resulted in rapid global spread of the disease, leading to significant economic losses within the swine industry. A significant obstacle to the creation of safe and effective ASF vaccines is the existing knowledge gap regarding the pathogenesis of ASFV and its mechanisms of immune evasion. The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway is a major pathway mediating type I interferon (IFN) antiviral immune response against infections by diverse classes of pathogens that contain DNA or generate DNA in their life cycles. To evade the host’s innate immune response, ASFV encodes many proteins that inhibit the production of type I IFN by antagonizing the cGAS-STING signaling pathway. Multiple proteins of ASFV are involved in promoting viral replication by protein–protein interaction during ASFV infection. The protein QP383R could impair the function of cGAS. The proteins EP364R, C129R and B175L could disturb the function of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). The proteins E248R, L83L, MGF505-11L, MGF505-7R, H240R, CD2v, E184L, B175L and p17 could interfere with the function of STING. The proteins MGF360-11L, MGF505-7R, I215L, DP96R, A151R and S273R could affect the function of TANK Binding Kinase 1 (TBK1) and IκB kinase ε (IKKε). The proteins MGF360-14L, M1249L, E120R, S273R, D129L, E301R, DP96R, MGF505-7R and I226R could inhibit the function of Interferon Regulatory Factor 3 (IRF3). The proteins MGF360-12L, MGF505-7R/A528R, UBCv1 and A238L could inhibit the function of nuclear factor kappa B (NF-Κb). Full article
(This article belongs to the Special Issue Infection and Immunity in Animals)
Show Figures

Figure 1

Back to TopTop